Cargando…

ILC2s—Trailblazers in the Host Response Against Intestinal Helminths

Group 2 innate lymphoid cells (ILC2s) were first discovered in experimental studies of intestinal helminth infection—and much of our current knowledge of ILC2 activation and function is based on the use of these models. It is perhaps not surprising therefore that these cells have also been found to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouchery, Tiffany, Le Gros, Graham, Harris, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458269/
https://www.ncbi.nlm.nih.gov/pubmed/31019505
http://dx.doi.org/10.3389/fimmu.2019.00623
_version_ 1783409974808936448
author Bouchery, Tiffany
Le Gros, Graham
Harris, Nicola
author_facet Bouchery, Tiffany
Le Gros, Graham
Harris, Nicola
author_sort Bouchery, Tiffany
collection PubMed
description Group 2 innate lymphoid cells (ILC2s) were first discovered in experimental studies of intestinal helminth infection—and much of our current knowledge of ILC2 activation and function is based on the use of these models. It is perhaps not surprising therefore that these cells have also been found to play a key role in mediating protection against these large multicellular parasites. ILC2s have been intensively studied over the last decade, and are known to respond quickly and robustly to the presence of helminths—both by increasing in number and producing type 2 cytokines. These mediators function to activate and repair epithelial barriers, to recruit other innate cells such as eosinophils, and to help activate T helper 2 cells. More recent investigations have focused on the mechanisms by which the host senses helminth parasites to activate ILC2s. Such studies have identified novel stromal cell types as being involved in this process—including intestinal tuft cells and enteric neurons, which respond to the presence of helminths and activate ILC2s by producing IL-25 and Neuromedin, respectively. In the current review, we will outline the latest insights into ILC2 activation and discuss the requirement for—or redundancy of—ILC2s in providing protective immunity against intestinal helminth parasites.
format Online
Article
Text
id pubmed-6458269
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64582692019-04-24 ILC2s—Trailblazers in the Host Response Against Intestinal Helminths Bouchery, Tiffany Le Gros, Graham Harris, Nicola Front Immunol Immunology Group 2 innate lymphoid cells (ILC2s) were first discovered in experimental studies of intestinal helminth infection—and much of our current knowledge of ILC2 activation and function is based on the use of these models. It is perhaps not surprising therefore that these cells have also been found to play a key role in mediating protection against these large multicellular parasites. ILC2s have been intensively studied over the last decade, and are known to respond quickly and robustly to the presence of helminths—both by increasing in number and producing type 2 cytokines. These mediators function to activate and repair epithelial barriers, to recruit other innate cells such as eosinophils, and to help activate T helper 2 cells. More recent investigations have focused on the mechanisms by which the host senses helminth parasites to activate ILC2s. Such studies have identified novel stromal cell types as being involved in this process—including intestinal tuft cells and enteric neurons, which respond to the presence of helminths and activate ILC2s by producing IL-25 and Neuromedin, respectively. In the current review, we will outline the latest insights into ILC2 activation and discuss the requirement for—or redundancy of—ILC2s in providing protective immunity against intestinal helminth parasites. Frontiers Media S.A. 2019-04-04 /pmc/articles/PMC6458269/ /pubmed/31019505 http://dx.doi.org/10.3389/fimmu.2019.00623 Text en Copyright © 2019 Bouchery, Le Gros and Harris. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Bouchery, Tiffany
Le Gros, Graham
Harris, Nicola
ILC2s—Trailblazers in the Host Response Against Intestinal Helminths
title ILC2s—Trailblazers in the Host Response Against Intestinal Helminths
title_full ILC2s—Trailblazers in the Host Response Against Intestinal Helminths
title_fullStr ILC2s—Trailblazers in the Host Response Against Intestinal Helminths
title_full_unstemmed ILC2s—Trailblazers in the Host Response Against Intestinal Helminths
title_short ILC2s—Trailblazers in the Host Response Against Intestinal Helminths
title_sort ilc2s—trailblazers in the host response against intestinal helminths
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458269/
https://www.ncbi.nlm.nih.gov/pubmed/31019505
http://dx.doi.org/10.3389/fimmu.2019.00623
work_keys_str_mv AT boucherytiffany ilc2strailblazersinthehostresponseagainstintestinalhelminths
AT legrosgraham ilc2strailblazersinthehostresponseagainstintestinalhelminths
AT harrisnicola ilc2strailblazersinthehostresponseagainstintestinalhelminths